Human hepatic preneoplasia: Phenotypes and proliferation kinetics of foci and nodules of altered hepatocytes and their relationship to liver cell dysplasia

Virchows Archiv

Volumn 431, Issue 6, 1997, Pages 391-406

  Su, Qin ^a   Benner, Axel ^a   Hofmann, Walter J ^b   Otto, Gerd ^b   Pichlmayr, Rudolf ^c   Bannasch, Peter ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c LEIBNIZ UNIVERSITY HANNOVER   (Germany)

Author keywords

Foci of altered hepatocytes; Hepatocellular carcinoma; Liver cell dysplasia; Liver cirrhosis; Proliferating cell nuclear antigen

Indexed keywords

GLYCOGEN;

ADOLESCENT; ADULT; AGED; ALCOHOL ABUSE; ARTICLE; BASOPHIL; CELL KINETICS; CELL PROLIFERATION; CHILD; DYSPLASIA; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN TISSUE; LIVER CELL; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER NODULE; MAJOR CLINICAL STUDY; PRECANCER; PRESCHOOL CHILD; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CELL DIVISION; CHILD; CHILD, PRESCHOOL; FEMALE; GLYCOGEN; HEPATITIS; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; LIVER CIRRHOSIS; LIVER DISEASES; LIVER NEOPLASMS; MALE; MIDDLE AGED; PRECANCEROUS CONDITIONS; PROLIFERATING CELL NUCLEAR ANTIGEN;

EID: 0030660181     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004280050116     Document Type: Article

References (74)

1. Aihara T, Noguchi S, Sasaki Y, Nakano H, Imaoka S (1994) Clonal analysis of regenerative nodules in hepatitis C virus-induced liver cirrhosis. Gastroenterol 107:1805-1811
2. Altmann HW (1994) Hepatic neoformations. Pathol Res Pract 190:513-577
3. Anthony PP, Vogel CL, Barker LF (1973) Liver cell dysplasia: a premalignant condition. J Clin Pathol 26:217-223
4. Armitage P (1955) Test for linear trend in proportions and frequencies. Biometrics 11:375-386
5. Balázs M (1976) Lichtmikroskopische Untersuchungen in einem Fall von primärem Leberkarzinom im Säuglingsalter. Zentralbl allgem Pathol 120:3-13
6. Bannasch P (1986) Preneoplastic lesions as end points in carcinogenicity testing. I. Hepatic preneoplasia. Carcinogenesis 7:849-852
7. Bannasch P (1996) Pathogenesis of hepatocellular cacinoma: sequential cellular, molecular, and metabolic changes. In: Boyer JL, Ockner RK (eds) Progress in liver diseases, vol 14. Saunders, Philadelphia, pp 161-197
8. Bannasch P, Mayer D, Hacker HJ (1980) Hepatocellular glycogenosis and hepatocarcinogenesis. Biochim Biophys Acta 605:217-245
9. 1 in woodchucks. Cancer Res 55:3318-3330
10. Bannasch P, Zerban H, Hacker HJ (1997) Foci of altered hepatocytes, rat. In: Jones TC, Popp J, Mohr U (eds) Monographs on pathology of laboratory animals. Digestive system. Springer, Berlin Heidelberg New York Tokyo, pp 3-37
11. Bannasch P, Jahn U-R, Hacker HJ, Su Q, Hofmann W, Pichlmayr R, Otto G (1997) Focal hepatic glycogenosis: a putative preneoplastic lesion associated with neoplasia and cirrhosis in explanted human livers. Int J Oncol 10:261-268
12. Bartoloni S, Omer F, Giannini A, Napoli P (1984) Hepatocellular carcinoma and cirrhosis: a review of their relative incidence in a 25-year period in the Florence area. Hepatogastroenterology 31:215-217
13. Benjamin DR, Gown AM (1991) Aberrant cytoplasmic expression of proliferating cell nuclear antigen in Hodgkin's disease. Am J Clin Pathol 15:764-768
14. Borzio M, Bruno S, Mels GC, Ramella G, Borzio F, Leandro G, Servida E, Podda M (1995) Liver cell dysplasia is a major risk factor for hepatocellular carcinoma in cirrhosis: a prospective study. Gastroenterology 108:812-817
15. Bosch FX, Muñoz N (1989) Epidemiology of hepatocellular carcinoma. In: Bannasch P, Keppler D, Weber G (eds) Liver cell carcinoma. Kluwer Academic, Dordrecht Boston London, pp 3-14
16. Cain H, Kraus B (1977) Entwicklungsstörungen der Leber und Leberkarzinom im Säuglings- und Kindesalter. Dtsch Med Wochenschr 102:505-509
17. Canne-Carrié N, Chastang C, Munz C, Pateron D, Sibony M, Déng P, Trinchet J-C, Callard P, Guettier C, Beaugrand M (1996) Predictive score for the development of hepatocellular carcinoma and additional value of liver cell dysplasia in western patients with cirrhosis. Hepatology 23:1112-1118
18. Caselmann WH, Alt M (1996) Hepatitis C virus infection as a major risk factor for hepatocellular carcinoma. J Hepatol 24 [Suppl 2]:61-66
19. Chang A, Harawi SJ (1992) Oncocytes, oncocytosis, and oncocytic tumors. Pathol Annu 27:263-304
20. Cleveland WS, Grosse E (1991) Computational methods for local regression. Statistics and Computing 1:47-62
21. 2 test. Biometrics 10:417-454
22. Cohen C, Berson SD (1986) Liver cell dysplasia in normal, cirrhotic and hepatocellular carcinoma patients. Cancer 57:1535-1538
23. Columbano A, Ledda-Columbano GM, Rao PM, Rajalakshmi S, Sarma DSR (1984) Occurrence of cell death (apoptosis) in preneoplastic and neoplastic liver cells: a sequential study. Am J Pathol 116:441-446
24. Craig JR, Peters RL, Edmondson HA (1989) Tumors of the liver and intrahepatic bile ducts. Armed Forces Institute of Pathology, Washington DC, pp 6-7
25. Deugnier YD, Charalambous P, Le Quilleuc D, Turlin B, Searle J, Brissot P, Powell LW, Halliday JW (1993) Preneoplastic significance of hepatic iron-free foci in genetic haemochromatosis: a study of 185 patients. Hepatology 18:1363-1369
26. Edmondson HA, Steiner PE (1954) Primary carcinoma of the liver: a study of 100 cases among 48900 necropsies. Cancer 7:462-503
27. Enzmann H, Bannasch P (1987) Potential significance of phenotypic heterogeneity of focal lesions at different stages in hepatocarcinogenesis. Carcinogenesis 8:1607-1612
28. Eriksson S, Carlson J, Velez R (1986) Risk of cirrhosis and primary liver cancer in alpha-1-antitrypsin deficiency. N Engl J Med 314:736-739
29. Ferrel LD, Crawford JM, Dhillon AP, Scheuer PJ, Nakanuma Y (1993) Proposal for standardized criteria for the diagnosis of benign, borderline, and malignant hepatocellular lesions arising in chronic advanced liver disease. Am J Surg Pathol 17:1113-1123
30. Fischer G, Hartmann H, Droese M, Schauer A, Bock KW (1986) Histochemical and immunohistochemical detection of putative preneoplastic liver foci in women after long-term use of oral contraceptives. Virchows Arch [B] 50:321-337
31. Gaffey MJ, Iezzoni JC, Weiss LM (1996) Clonal analysis of focal nodular hyperplasia of the liver. Am J Pathol 148:1089-1096
32. Gerber MA, Thung SN (1981) Hepatic oncocytes. Incidence, staining characteristics, and ultrastructural features. Am J Clin Pathol 75:498-503
33. Goodman DG, Maronpot RR, Newberne PM, Popp JA, Squire RA (1994) Proliferative and selected other lesions of the liver in rats. In: Guides for toxicologic pathology. STP/ARP/AFIP, Washington DC, pp 1-24
34. Harris CC (1995) 1995 Deichmann Lecture - p53 tumor suppressor gene: at the crossroads of molecular carcinogenesis, molecular epidemiology and cancer risk assessment. Toxicol Lett 82/83:1-7
35. Hirota N, Hamazaki M, Williams GM (1982) Resistance to iron accumulation and presence of hepatitis B surface antigen in preneoplastic and neoplastic lesions in human haemochromatotic livers. Hepatogastroenterol 29:49-51
36. Holm S (1979) A simple sequentially rejective multiple test procedure. Scand J Statist 6:65-67
37. Hytigoglou P, Theise ND, Schwartz M, Mor E, Miller C, Thung SN (1995) Macroregenerative nodules in a series of adult cirrhotic liver explants: issues of classification and nomenclature. Hepatology 21:703-708
38. Imaida K, Tatematsu M, Kato T, Tsuda H, Ito N (1989) Advantages and limitations of stereological estimation of placental glutathione S -transferase-positive rat liver foci by computerized three-dimensional reconstruction. Jpn J Cancer Res 80:326-330
39. International Working Party (1995) Terminology of nodular hepatocellular lesions. Hepatology 22:983-993
40. Ishak KG, Anthony PP, Sobin LH (1994) Histological typing of tumours of the liver. In: World Health Organization, International histological classification of tumours, 2nd edn. Springer, Berlin Heidelberg New York, pp 9-22
41. Ismail T, Angrisani L, Hubscher S, McMaster P (1991) Hepatocellular carcinoma complicating primary sclerosing cholangitis. Br J Surg 78:360-361
42. Karhunen PJ, Penttilä A (1987) Preneoplastic lesions of human liver. Hepatogastroenterology 34:10-15
43. Kawai S, Imazeki F, Yokosuka O, Ohta M, Shiina S, Kato N, Omata M (1995) Clonality in hepatocellular carcinoma: analysis of methylation pattern of polymorphic X-chromosome-linked phosphoglycerate kinase gene in females. Hepatology 22:112-117
44. Le Bail B, Belleannée G, Bernard P-H, Saric J, Balabaud C, Bioulac-Sage P. (1995) Adenomatous hyperplasia in cirrhotic livers: histological evaluation, cellular density, and proliferative activity of 35 macronodular lesions in the cirrhotic explants of 10 adult French patients. Hum Pathol 26:897-906
45. Lefkowitch JH, Arborgh BÅ M, Scheuer PJ (1980) Oxyphilic granular hepatocytes: mitochondria-rich liver cells in hepatic-disease. Am J Clin Pathol 74:432-441
46. Lehmann EL (1975) Nonparametrics: statistical methods based on ranks. Holden and Day, San Francisco
47. Marsman DS, Popp JA (1994) Biologic potential of basophilic hepatocellular foci and hepatic adenoma induced by the peroxisome proliferator, Wy-14, 643. Carcinogenesis 15:111-117
48. Metzger C, Mayer D, Hoffmann H, Bocker T, Hobe G, Benner A, Bannasch P (1995) Sequential appearance and ultrastructure of amphophilic cell foci, adenomas, and carcinomas in the liver of male and female rats treated with dehydroepiandrosterone. Toxicol Pathol 23:591-605
49. Nakanuma Y, Hirata K (1993) Unusual hepatocellular lesions in primary biliary cirrhosis resembling but unrelated to hepatocellular carcinoma. Virchows Arch [A] Path Anal 422:17-23
50. Nakanuma Y, Terada T, Doishita K, Miwa A (1990) Hepato-cellular carcinoma in primary biliary cirrhosis: an autopsy study. Hepatology 11:1010-1016
51. Nakashima T, Okuda K, Kojiro M, Jimi A, Yamaguchi R, Sakamoto K, Ikari T (1983) Pathology of hepatocellular carcinoma in Japan, 232 consecutive cases autopsied in 10 years. Cancer 51:863-877
52. Niederau C, Fischer R, Sonnenberg A, Stremmel W, Trampisch HJ, Strohmeyer G (1985) Survival and causes of death in cirrhotic and noncirrhotic patients with primary haemochromatosis. N Engl J Med 313:1256-1262
53. Okuda K (1982) Membranous obstruction of the inferior vena cava: etiology and relation to hepatocellular carcinoma. Gastroenterology 82:376-379
54. Okuda K (1992) Hepatocellular carcinoma: recent progress. Hepatol 15:948-963
55. Okuda K, Fujimoto I, Hanai A, Urano Y (1987) Changing incidence of hepatocellular carcinoma in Japan. Cancer Res 47:4967-4972
56. Payne CM, Nagle RB, Paplanus SH, Graham AR (1986) Fibrolamellar carcinoma of liver: a primary malignant oncocytic carcinoid? Ultrastruct Pathol 10:539-552
57. Pilot HC (1990) Altered hepatic foci: their role in murine hepatocarcinogenesis. Annu Rev Pharmacol Toxicol 30:465-500
58. Polio J, Enriquez RE, Chow A, Wood WM, Atterbury CE (1989) Hepatocellular carcinoma in Wilson's disease. J Clin Gstroenterol 11:220-224
59. Salisbury JR, Portmann BC (1987) Oncocytic liver cell adenoma. Histopathology 11:533-539
60. Savolainen V, Perola M, Lalu K, Pentttilä A, Virtanen I, Karhunen PJ (1995) Early perivenular fibrogenesis - precirrhotic lesions among moderate alcohol consumers and chronic alcoholics. J Hepatol 23:524-531
61. Schulte-Hermann R, Bursch W, Grasl-Kraupp B, Mülauer L, Ruttkay-Nedecky B (1995) Apoptosis and multistage carcinogenesis in rat liver. Mutat Res 333:81-87
62. Su Q, Liu YF, Zhang, JF, Zhang SX, Yang JJ (1994) Expression of insulin-like growth factor II in hepatitis, cirrhosis and hepatocellular carcinoma: its relationship with hepatitis B virus antigen expression. Hepatology 20:788-799
63. Su Q, Zhang SX, Yang SJ, Liu J, Liu YF (1995) Precancerous changes in hepatitis B and liver cirrhosis: a morphological and immunohistochemical study. J Fourth Milit Med Univ 16:85-88
64. Tabor E (1994) Tumor suppressor genes, growth factor genes, and oncogenes in hepatitis B virus-associated hepatocellular carcinoma. J Med Virol 42:357-365
65. Tsuda H, Hirohashi S, Shimosato Y, Terada M, Hasegavva H (1988) Clonal origin of atypical adenomatous hyperplasia of the liver and clonal identity with hepatocellular carcinoma. Gastroenterology 95:1664-1666
66. Tsunashima K, Endo Y, Asakura H, Kanda H, Nomura K, Kitagawa T, Kominami R (1996) A novel clonal assay for the mouse: application to hepatocellular carcinomas induced with diethylnitrosamine. Mol Carcinog 15:33-37
67. Ugarte N, Gonzalez-Crussi F (1981) Hepatoma in siblings with progressive familial cholestatic cirrhosis of childhood. Am J Clin Pathol 76:172-177
68. Watanabe S, Okita K, Harada T, Kodama T, Numa Y, Takemoto T, Takahashi T (1983) Morphologic studies of the liver cell dysplasia. Cancer 51:2197-2205
69. Weber E, Bannasch P (1994) Dose und time dependence of the cellular phenotype in rat hepatic preneoplasia and neoplasia induced by continuous oral exposure to N -nitrosomorpholine. Carcinogenesis 15:1235-1240
70. Weinberg WC, Ng YK, Iannaccone PM (1992) Clonal analysis of hepatic neoplasms by mosaic pattern. In: Sirica AE (ed) The role of cell types in hepatocarcinogenesis. CRC Press, Boca Raton Ann Arbor London, pp 29-53
71. Williams GM (1980) The pathogenesis of rat liver cancer caused by chemical carcinogens. Biochim Biophys Acta 605:167-189
72. Yasui H, Hino O, Ohtake K, Machinami R, Kitagawa T (1992) Clonal growth of hepatits B-integrated hepatocytes in cirrhotic liver nodules. Cancer Res 52:6810-6814
73. Zerban H, Radig S, Kopp-Schneider A, Bannasch P (1994) Cell proliferation and cell death (apoptosis) in hepatic preneoplasia and neoplasia are closely related to phenotypic cellular diversity and instability. Carcinogenesis 15:2467-2473
74. Zhao M, Zhang NX, Du ZY, Laissue JA, Zimmermann A (1994) Three types of liver cell dysplasia (LCD) in small cirrhotic nodules are distinguishable by karyometry and PCNA labelling, and their features resemble distinct grades of hepatocellular carcinoma. Histol Histopathol 9:73-83